Literature DB >> 18291472

Neuroprotective effect of erythropoietin after experimental cold injury-induced vasogenic brain edema in rats.

Ozerk Okutan1, Omer Faruk Turkoglu, Hayriye Beril Gok, Etem Beskonakli.   

Abstract

BACKGROUND: The aims of this study were to evaluate the efficiency of EPO in the treatment of cold injury-induced brain edema, apoptosis, and inflammation and to compare its effectiveness with DSP.
METHODS: One hundred fifteen adult male Sprague-Dawley rats weighing between 280 and 300 g were used for the study. Rats were divided into 5 groups. Controls received craniotomy only. The injury group underwent cold injury and had no medication. In the EPO group, a single dose of 1000 IU/kg body weight of EPO was administered. The DSP group received 0.2 mg/kg body weight of DSP. The vehicle group received a vehicle solution containing human serum albumin, which is the solvent for EPO. Brain edema was formed by cold injury using metal sterile rods with a diameter of 4 mm that were previously cooled at -80 degrees C. Twenty-four hours after the injury, animals were decapitated and brain tissues were investigated for brain edema, tissue MPO and caspase-3 levels, and ultrastructure.
RESULTS: A significant increase in brain water content was revealed in injury group of rats at 24 hours after cold injury. Injury significantly increased tissue MPO and caspase-3 levels and resulted in ultrastructural damage. Both EPO and DSP markedly decreased tissue MPO and caspase-3 levels and preserved ultrastructure of the injured brain cortex.
CONCLUSIONS: Erythropoietin and DSP were found to be neuroprotective in cold injury-induced brain edema model in rats via anti-apoptotic and anti-inflammatory actions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18291472     DOI: 10.1016/j.surneu.2007.07.061

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  6 in total

Review 1.  Novel avenues of drug discovery and biomarkers for diabetes mellitus.

Authors:  Kenneth Maiese; Zhao Zhong Chong; Yan Chen Shang; Jinling Hou
Journal:  J Clin Pharmacol       Date:  2010-03-10       Impact factor: 3.126

2.  Diabetes mellitus: channeling care through cellular discovery.

Authors:  Kenneth Maiese; Yan Chen Shang; Zhao Zhong Chong; Jinling Hou
Journal:  Curr Neurovasc Res       Date:  2010-02       Impact factor: 1.990

3.  Nonerythropoietic, tissue-protective peptides derived from the tertiary structure of erythropoietin.

Authors:  Michael Brines; Nimesh S A Patel; Pia Villa; Courtenay Brines; Tiziana Mennini; Massimiliano De Paola; Zubeyde Erbayraktar; Serhat Erbayraktar; Bruno Sepodes; Christoph Thiemermann; Pietro Ghezzi; Michael Yamin; Carla C Hand; Qiao-wen Xie; Thomas Coleman; Anthony Cerami
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-01       Impact factor: 11.205

4.  Delayed administration of erythropoietin reducing hippocampal cell loss, enhancing angiogenesis and neurogenesis, and improving functional outcome following traumatic brain injury in rats: comparison of treatment with single and triple dose.

Authors:  Ye Xiong; Asim Mahmood; Yuling Meng; Yanlu Zhang; Changsheng Qu; Timothy Schallert; Michael Chopp
Journal:  J Neurosurg       Date:  2010-09       Impact factor: 5.115

Review 5.  Oxidative stress: Biomarkers and novel therapeutic pathways.

Authors:  Kenneth Maiese; Zhao Zhong Chong; Jinling Hou; Yan Chen Shang
Journal:  Exp Gerontol       Date:  2010-01-11       Impact factor: 4.032

6.  Erythropoietin regulates immune/inflammatory reaction and improves neurological function outcomes in traumatic brain injury.

Authors:  Zi-Wei Zhou; Fei Li; Zhi-Tong Zheng; Ya-Dan Li; Tong-Heng Chen; Wei-Wei Gao; Jie-Li Chen; Jian-Ning Zhang
Journal:  Brain Behav       Date:  2017-10-03       Impact factor: 2.708

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.